Discontinued — last reported Q2 '25
Other
Components
Pfizer Components remained flat by 0.0% to $239.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $198.00M to $239.00M.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2022
Last reportedQ2 2025
How to read this metric
Changes in components provide insight into the shifting nature of the underlying asset or liability class.
Detailed definition
This is a generic placeholder used to categorize or aggregate specific sub-items within a financial statement line item....
Peer comparison
Varies significantly based on specific accounting disclosures.
Metric ID:
componentsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $98.00M | $151.00M | $167.00M | $194.00M | $201.00M | $203.00M | $200.00M | $213.00M | $212.00M | $214.00M | $198.00M | $223.00M | $239.00M | $239.00M |
| QoQ Change | — | +54.1% | +10.6% | +16.2% | +3.6% | +1.0% | -1.5% | +6.5% | -0.5% | +0.9% | -7.5% | +12.6% | +7.2% | +0.0% |
| YoY Change | — | — | — | +98.0% | +33.1% | +21.6% | +3.1% | +6.0% | +4.4% | +7.0% | -7.0% | +5.2% | +11.7% | +20.7% |
Range$98.00M – $239.00M
CAGR+31.6%
Avg YoY Growth+18.5%
Median YoY Growth+7.0%
Current Streak3 quarters growth
Components at Other Companies
Frequently Asked Questions
- What is Pfizer's components?
- Pfizer (PFE) reported components of $239.00M in Q3 2025.
- How has Pfizer's components changed year-over-year?
- Pfizer's components increased by 20.7% year-over-year, from $198.00M to $239.00M.
- What does components mean?
- A breakdown of specific items within a larger financial category.